Allianz Asset Management’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,783
Closed -$1.09M 2501
2021
Q1
$1.09M Buy
18,783
+35
+0.2% +$2.19K ﹤0.01% 1611
2020
Q4
$1.1M Sell
18,748
-251
-1% -$13.5K ﹤0.01% 1462
2020
Q3
$905K Sell
18,999
-1,426
-7% -$64.7K ﹤0.01% 1453
2020
Q2
$912K Buy
+20,425
New +$816K ﹤0.01% 1853

Other funds holding BTEC

Allianz Asset Management's BTEC Position: Q2 2021 in Review

Allianz Asset Management sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q2 2021, closing a stake of 18,783 shares — an estimated $1.09M sold.

Allianz Asset Management first reported a position in BTEC in Q2 2020 and held it in 4 quarters. The position peaked at $1.1M in Q4 2020. 33 funds tracked by Wall St. Rank hold BTEC as of Q2 2021.

  • Allianz Asset Management reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q2 2021 after selling out during the quarter.
  • Allianz Asset Management sold 18,783 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q2 2021, an estimated $1.09M.
  • Allianz Asset Management first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q2 2020 and held it in 4 quarters.
  • Allianz Asset Management's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $1.1M in Q4 2020.
  • 33 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q2 2021.

Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.